K2 cardiovascular patents to bolster PLT's position
PL Thomas is set to reap the benefits of three pending patents in the area of natural vitamin K2 and cardiovascular health which Natto Pharma, whose MenaQ7 PLT markets in the US, has obtained from VitaK.